Jachs, M.; Hartl, L.; Bauer, D.; Simbrunner, B.; Stättermayer, A.F.; Strassl, R.; Trauner, M.; Mandorfer, M.; Reiberger, T.
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression. J. Pers. Med. 2022, 12, 239.
https://doi.org/10.3390/jpm12020239
AMA Style
Jachs M, Hartl L, Bauer D, Simbrunner B, Stättermayer AF, Strassl R, Trauner M, Mandorfer M, Reiberger T.
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression. Journal of Personalized Medicine. 2022; 12(2):239.
https://doi.org/10.3390/jpm12020239
Chicago/Turabian Style
Jachs, Mathias, Lukas Hartl, David Bauer, Benedikt Simbrunner, Albert Friedrich Stättermayer, Robert Strassl, Michael Trauner, Mattias Mandorfer, and Thomas Reiberger.
2022. "Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression" Journal of Personalized Medicine 12, no. 2: 239.
https://doi.org/10.3390/jpm12020239
APA Style
Jachs, M., Hartl, L., Bauer, D., Simbrunner, B., Stättermayer, A. F., Strassl, R., Trauner, M., Mandorfer, M., & Reiberger, T.
(2022). Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression. Journal of Personalized Medicine, 12(2), 239.
https://doi.org/10.3390/jpm12020239